1064 related articles for article (PubMed ID: 17477859)
41. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.
Chen AY; Jemal A; Ward EM
Cancer; 2009 Aug; 115(16):3801-7. PubMed ID: 19598221
[TBL] [Abstract][Full Text] [Related]
42. Breast cancer incidence and mortality--United States, 1992.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(39):833-7. PubMed ID: 8864142
[TBL] [Abstract][Full Text] [Related]
43. Age-related lobular involution and risk of breast cancer.
Milanese TR; Hartmann LC; Sellers TA; Frost MH; Vierkant RA; Maloney SD; Pankratz VS; Degnim AC; Vachon CM; Reynolds CA; Thompson RA; Melton LJ; Goode EL; Visscher DW
J Natl Cancer Inst; 2006 Nov; 98(22):1600-7. PubMed ID: 17105983
[TBL] [Abstract][Full Text] [Related]
44. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms.
Kravchenko J; Akushevich I; Seewaldt VL; Abernethy AP; Lyerly HK
Breast Cancer Res Treat; 2011 Jul; 128(2):483-93. PubMed ID: 21225455
[TBL] [Abstract][Full Text] [Related]
45. Increase in incidence of colorectal cancer among young men and women in the United States.
Siegel RL; Jemal A; Ward EM
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1695-8. PubMed ID: 19505901
[TBL] [Abstract][Full Text] [Related]
46. Type and duration of exogenous hormone use affects breast cancer histology.
Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES
Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262
[TBL] [Abstract][Full Text] [Related]
47. Ethnicity and breast cancer in Hawaii: increased survival but continued disparity.
Braun KL; Fong M; Gotay C; Pagano IS; Chong C
Ethn Dis; 2005; 15(3):453-60. PubMed ID: 16108306
[TBL] [Abstract][Full Text] [Related]
48. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
[TBL] [Abstract][Full Text] [Related]
49. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
[TBL] [Abstract][Full Text] [Related]
50. Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme.
Ascunce EN; Moreno-Iribas C; Barcos Urtiaga A; Ardanaz E; Ederra Sanz M; Castilla J; Egüés N
J Med Screen; 2007; 14(1):14-20. PubMed ID: 17362566
[TBL] [Abstract][Full Text] [Related]
51. Breast carcinoma survival in Europe and the United States.
Sant M; Allemani C; Berrino F; Coleman MP; Aareleid T; Chaplain G; Coebergh JW; Colonna M; Crosignani P; Danzon A; Federico M; Gafà L; Grosclaude P; Hédelin G; Macè-Lesech J; Garcia CM; Møller H; Paci E; Raverdy N; Tretarre B; Williams EM;
Cancer; 2004 Feb; 100(4):715-22. PubMed ID: 14770426
[TBL] [Abstract][Full Text] [Related]
52. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data.
Hock LM; Lynch J; Balaji KC
J Urol; 2002 Jan; 167(1):57-60. PubMed ID: 11743275
[TBL] [Abstract][Full Text] [Related]
53. Breast cancer in New Zealand: trends, patterns, and data quality.
Armstrong W; Borman B
N Z Med J; 1996 Jun; 109(1024):221-4. PubMed ID: 8769030
[TBL] [Abstract][Full Text] [Related]
54. [Time trends in cancer incidence in Osaka].
Hanai A; Fujimoto I
Gan To Kagaku Ryoho; 1984 Mar; 11(3):367-76. PubMed ID: 6703715
[TBL] [Abstract][Full Text] [Related]
55. Trends in the incidence of invasive and in situ vulvar carcinoma.
Judson PL; Habermann EB; Baxter NN; Durham SB; Virnig BA
Obstet Gynecol; 2006 May; 107(5):1018-22. PubMed ID: 16648405
[TBL] [Abstract][Full Text] [Related]
56. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
[TBL] [Abstract][Full Text] [Related]
57. Trends in invasive breast cancer incidence among French women not exposed to organized mammography screening: an age-period-cohort analysis.
Viel JF; Rymzhanova R; Fournier E; Danzon A
Cancer Epidemiol; 2011 Dec; 35(6):521-5. PubMed ID: 21621498
[TBL] [Abstract][Full Text] [Related]
58. Patient and tumor characteristics associated with primary tumor resection in women with Stage IV breast cancer: analysis of 1988-2003 SEER data.
Gnerlich J; Dueker JM; Jeffe DB; Deshpande AD; Thompson S; Margenthaler JA
Breast J; 2008; 14(6):538-42. PubMed ID: 19000055
[TBL] [Abstract][Full Text] [Related]
59. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands.
Louwman WJ; Voogd AC; van Dijck JA; Nieuwenhuijzen GA; Ribot J; Pruijt JF; Coebergh JW
Cancer Causes Control; 2008 Feb; 19(1):97-106. PubMed ID: 18038250
[TBL] [Abstract][Full Text] [Related]
60. Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy.
Sharpe KH; McClements P; Clark DI; Collins J; Springbett A; Brewster DH
Eur J Cancer; 2010 Mar; 46(5):937-43. PubMed ID: 20122823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
